Is 8WF undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 8WF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 8WF (€96.18) is trading below our estimate of fair value (€690.86)
Significantly Below Fair Value: 8WF is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 8WF?
Key metric: As 8WF is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 8WF. This is calculated by dividing 8WF's market cap by their current
revenue.
What is 8WF's PS Ratio?
PS Ratio
1.9x
Sales
US$4.06b
Market Cap
US$7.62b
8WF key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 8WF is good value based on its Price-To-Sales Ratio (1.9x) compared to the European Diversified Financial industry average (2x).
Price to Sales Ratio vs Fair Ratio
What is 8WF's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
8WF PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
1.9x
Fair PS Ratio
2.7x
Price-To-Sales vs Fair Ratio: 8WF is good value based on its Price-To-Sales Ratio (1.9x) compared to the estimated Fair Price-To-Sales Ratio (2.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 8WF forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€96.18
€96.54
+0.4%
9.8%
€111.62
€83.95
n/a
5
Nov ’25
€91.30
€83.38
-8.7%
13.1%
€101.48
€67.65
n/a
5
Oct ’25
€80.36
€77.97
-3.0%
14.3%
€98.36
€66.78
n/a
5
Sep ’25
€77.30
€71.94
-6.9%
7.8%
€80.29
€66.76
n/a
4
Aug ’25
€80.24
€73.45
-8.5%
4.5%
€77.61
€68.37
n/a
4
Jul ’25
€67.84
€71.25
+5.0%
6.4%
€76.62
€65.41
n/a
4
Jun ’25
€68.44
€68.90
+0.7%
10.4%
€75.58
€57.15
n/a
4
May ’25
€63.48
€61.64
-2.9%
11.7%
€70.58
€51.76
n/a
4
Apr ’25
€60.50
€53.06
-12.3%
10.8%
€62.75
€47.99
n/a
4
Mar ’25
€49.95
€53.06
+6.2%
10.8%
€62.75
€47.99
n/a
4
Feb ’25
€45.75
€46.87
+2.4%
5.9%
€50.55
€43.19
n/a
5
Jan ’25
€46.20
€40.81
-11.7%
13.9%
€50.56
€34.93
n/a
5
Dec ’24
€43.15
€40.02
-7.2%
10.6%
€46.11
€35.04
n/a
5
Nov ’24
€34.15
€36.93
+8.2%
10.1%
€43.34
€32.03
€91.30
5
Oct ’24
€35.45
€36.27
+2.3%
10.3%
€43.23
€31.95
€80.36
5
Sep ’24
€34.15
€34.39
+0.7%
5.2%
€36.78
€31.26
€77.30
5
Aug ’24
€29.55
€34.37
+16.3%
4.6%
€36.37
€31.82
€80.24
5
Jul ’24
€27.60
€34.52
+25.1%
4.3%
€36.72
€32.13
€67.84
5
Jun ’24
€25.45
€35.12
+38.0%
6.1%
€38.61
€32.18
€68.44
5
May ’24
€31.75
€37.86
+19.2%
9.1%
€43.68
€33.67
€63.48
5
Apr ’24
€33.11
€38.43
+16.1%
9.9%
€44.77
€33.58
€60.50
5
Mar ’24
€41.86
€39.95
-4.5%
15.5%
€51.58
€33.76
€49.95
5
Feb ’24
€42.00
€36.88
-12.2%
8.5%
€42.63
€33.36
€45.75
5
Jan ’24
€32.91
€37.27
+13.3%
11.0%
€44.64
€33.00
€46.20
5
Dec ’23
€35.13
€37.27
+6.1%
11.0%
€44.64
€33.00
€43.15
5
Nov ’23
€37.84
€36.85
-2.6%
8.4%
€42.99
€34.80
€34.15
5
Analyst Forecast: Target price is lower than the current share price.